ENHANCED PROSTACYCLIN FORMATION IN VEINS OF WOMEN UNDER CHRONICAL TREATMENT WITH ORAL-CONTRACEPTIVE DRUGS

被引：23

作者：

SINZINGER, H

KLEIN, K

KALIMAN, J

SILBERBAUER, K

FEIGL, W

机构：

[1] AUSTRIAN ACAD SCI,ATHEROSCLEROSIS & THROMBOSIS RES COMMISS,A-1010 VIENNA,AUSTRIA

[2] VIENNA UNIV,DEPT CARDIOL,A-1010 VIENNA,AUSTRIA

[3] VIENNA UNIV,DEPT INTERNAL MED 2,A-1010 VIENNA,AUSTRIA

[4] VIENNA UNIV,DEPT PATHOL,A-1010 VIENNA,AUSTRIA

来源：

PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1980年 / 12卷 / 06期

关键词：

D O I：

10.1016/S0031-6989(80)80137-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：515 / 521

页数：7

共 50 条

[21] METABOLISM OF ORAL-CONTRACEPTIVE DRUGS - FORMATION AND DISAPPEARANCE OF METABOLITES OF NORETHINDRONE AND MESTRANOL AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
MILLS, TM
LIN, TJ
BRASELTON, WE
ELLEGOOD, JO
MAHESH, VB
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1976, 126 (08) : 987 - 992
[22] INHIBITION OF ORAL-CONTRACEPTIVE STEROID METABOLIZING ENZYMES BY STEROIDS AND DRUGS
GUENGERICH, FP
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (06) : 2159 - 2163
[23] THE RELATIONSHIP BETWEEN MOOD AND SEXUALITY IN WOMEN USING AN ORAL-CONTRACEPTIVE AS A TREATMENT FOR PREMENSTRUAL SYMPTOMS
GRAHAM, CA
SHERWIN, BB
PSYCHONEUROENDOCRINOLOGY, 1993, 18 (04) : 273 - 281
[24] PLASMA-LEVELS OF ADRENOCORTICOTROPIN AND CORTISOL IN WOMEN RECEIVING ORAL-CONTRACEPTIVE STEROID TREATMENT
CARR, BR
PARKER, CR
MADDEN, JD
MACDONALD, PC
PORTER, JC
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (03): : 346 - 349
[25] PHARMACOKINETICS OF LEVONORGESTREL IN 18 WOMEN AFTER 1 MONTH OF TREATMENT WITH A TRIPHASIC ORAL-CONTRACEPTIVE
KUHNZ, W
ALYACOUB, G
HORMONE RESEARCH, 1991, 35 (05) : 178 - 181
[26] EFFECTS OF ESTROGENS ON PROLACTIN AND THYROTROPIN RESPONSES TO TRH IN WOMEN DURING MENSTRUAL-CYCLE AND UNDER ORAL-CONTRACEPTIVE TREATMENT
REYMOND, M
LEMARCHANDBERAUD, T
CLINICAL ENDOCRINOLOGY, 1976, 5 (05) : 429 - 437
[27] SERUM PROFILES OF OXYTOCIN DURING ORAL-CONTRACEPTIVE TREATMENT
STOCK, S
KARLSSON, R
VONSCHOULTZ, B
GYNECOLOGICAL ENDOCRINOLOGY, 1994, 8 (02) : 121 - 126
[28] SPIRONOLACTONE IN COMBINATION WITH AN ORAL-CONTRACEPTIVE - AN ALTERNATIVE TREATMENT FOR HIRSUTISM
GUILLEBAUD, J
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1986, 93 (02): : 197 - 198
[29] THROMBOTIC THROMBOCYTOPOENIC PURPURA DURING ORAL-CONTRACEPTIVE TREATMENT
VESCONI, S
LANGER, M
ROSSI, E
MONDONICO, P
CAMBIAGHI, G
DONATI, MB
THROMBOSIS AND HAEMOSTASIS, 1979, 40 (03) : 563 - 564
[30] MYOCARDIAL-INFARCTION IN YOUNGER WOMEN - ASSOCIATED CLINICAL FEATURES AND RELATIONSHIP TO USE OF ORAL-CONTRACEPTIVE DRUGS
ARTHES, FG
MASI, AT
CHEST, 1976, 70 (05) : 574 - 583

← 1 2 3 4 5 →